The partnership between the pharmaceutical giant and the university aims to create a vaccine or vaccines which target cells ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.31 billion and an impressive gross profit margin of 72.39%, has announced that its new drug applications ...

Understanding those ingredients, will impart you the essentials of the pharmaceutical market in Egypt. GSK has understood the game of access in Egypt earlier than other companies. By buying two ...

Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently ...

Swiss biopharma company BioVersys said on Wednesday it had launched an initial public offering on the SIX stock exchange priced at 36 Swiss francs ($39.84) per share.

The deal will not only transform Novartis, but GSK as well, with both companies clearly focusing ... of assets shows that these three major pharma players are happy to pursue divergent strategies ...

Based in the United Kingdom, Haleon makes consumer health care products, including Advil, Centrum Multivitamin and Aquafresh ...

The pulmonary fibrosis market is driven by the increasing prevalence of pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF), among the aging population, which boosts demand for ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Learn more about whether Ionis Pharmaceuticals, Inc. or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.